A Pharmaceutical giant, Wellcome and the Bill & Melinda Gates Foundation have announced funding, to advance a tuberculosis (TB) vaccine candidate, M72/AS01E (M72), through a Phase III clinical trial.
Trending
- World Glaucoma Week 2025: UDUTH screens 167 journalists in Sokoto
- Governance as self-interest, By Prof. Jibrin Ibrahim
- World Kidney Day: Group advocates affordable post-transplant medications
- Niger govt dismisses claims of financial mismanagement
- Niger govt seeks Customs waiver to boost agriculture
- Airtel introduces AI-powered spam alert to combat fraud
- Local governments to directly manage PHCs funds following ruling
- NICRAT, Roche, Oncopadi launch BRANT app for breast cancer care
